Lek d.d., a prominent pharmaceutical company headquartered in Slovenia (SI), has been a key player in the industry since its establishment in 1946. With a strong presence in Central and Eastern Europe, Lek d.d. focuses on the development, production, and marketing of generic and innovative medicines, particularly in the fields of oncology, cardiovascular health, and central nervous system disorders. Renowned for its commitment to quality and innovation, Lek d.d. offers a diverse portfolio of products that cater to various therapeutic areas. The company has achieved significant milestones, including its integration into the Sandoz division of Novartis, enhancing its market position and global reach. Lek d.d. continues to be recognised for its contributions to healthcare, making it a trusted name in the pharmaceutical landscape.
How does Lek d. d.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Lek d. d.'s score of 51 is higher than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Lek d.d. reported total carbon emissions of approximately 63,453 kg CO2e, comprising 42,900 kg CO2e from Scope 1, 19,070 kg CO2e from Scope 2, and 1,483 kg CO2e from Scope 3 emissions. This marks a significant reduction from 2022, where total emissions were about 92,722 kg CO2e, with Scope 1 emissions at 59,500 kg CO2e, Scope 2 at 26,120 kg CO2e, and Scope 3 at 3,102 kg CO2e. Over the past few years, Lek has demonstrated a commitment to reducing its carbon footprint. In 2021, total emissions were approximately 99,539 kg CO2e, indicating a downward trend in emissions. The company has not publicly disclosed specific reduction targets or initiatives, nor does it appear to have cascaded targets from its parent company, Sandoz Group AG. Lek's emissions data is cascaded from its parent company, Sandoz Group AG, reflecting its current subsidiary status. The company has disclosed emissions across all three scopes, highlighting its comprehensive approach to climate accountability. However, no specific climate pledges or reduction initiatives have been identified in the available data.
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 30,866,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000 | 000,000 | 00,000 | 00,000 | 00,000 |
| Scope 2 | 29,613,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000 | 00,000 | 00,000 | 00,000 | 00,000 |
| Scope 3 | 30,239,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000 | 0,000 | 0,000 | 0,000 | 0,000 |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Lek d. d. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.